Lack of prognostic value of cathepsin D levels for predicting short term outcomes of breast cancer patients

Cancer Letters

Volumn 116, Issue 2, 1997, Pages 177-183

  Ravdin, P M ^a   De Moor, C A ^a   Hilsenbeck, S G ^a   Samoszuk, M K ^b   Vendely, P M ^b   Clark, G M ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

Author keywords

Breast cancer; Cathepsin D; Prognosis

Indexed keywords

CATHEPSIN D;

ADULT; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CLINICAL TRIAL; CYTOSOL; DIAGNOSTIC VALUE; ENZYME ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNORADIOMETRIC ASSAY; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PREDICTION; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; BREAST NEOPLASMS; CATHEPSIN D; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MIDDLE AGED; PROGNOSIS;

EID: 0030831239     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)00184-5     Document Type: Article

References (23)

1. Rochefort H. Cathepsin D in breast cancer: a tissue marker associated with metastasis. Eur. J. Cancer. 28A:1992;1780-1783.
2. Ravdin P.M. Evaluation of cathepsin D as a prognostic factor in breast cancer. Br. Cancer Res. Treat. 24:1993;219-226.
3. Goldhirsch A., Wood W.C., Senn H.-J. International consensus panel on the treatment of primary breast cancer. Eur. J. Cancer. 31A:1995;1754-1759.
4. Henson D.E., Fielding L.P., Grignon D.J.et al. College of American Pathologists Conference XXVI on clinical relevance of prognostic markers in solid tumors. Arch. Pathol. Lab. Med. 119:1995;1109-1112.
5. Rogier H., Freiss G., Basse M.-G.et al. Two site immunoenzymatic assay for the 52 kDa cathepsin D in cytosols of breast cancer tissues. Clin. Chem. 35:1989;81-85.
6. Wenger C.R., Beardslee S., Owens M.A.et al. DNA ploidy, S-phase and steroid receptors in more than 127 000 breast cancer patients. Breast Cancer Res. Treat. 28:1993;9-20.
7. Pujol P., Maudelonde T., Daures J.-P.et al. A prospective study of the prognostic value of cathepsin D levels in breast cancer cytosols. Cancer. 71:1993;2006-2012.
8. Isola J., Weitz S., Visakorpi T.et al. Cathepsin D expression detected by immunohistochemistry has independent prognostic value in axillary node-negative breast cancer. J. Clin. Oncol. 11:1993;36-43.
9. Tetu B., Brisson J., Cote C.et al. Prognostic significance of cathepsin D expression in node-positive breast carcinoma: an immunohistochemical study. Int. J. Cancer. 55:1993;429-435.
10. Kandalft P.L., Chang K.L., Ahn C.W. Prognostic significance of immunohistochemical analysis of cathepsin D in low-stage breast cancer. Cancer. 71:1993;2756-2763.
11. Joensuu H., Toikkanen S., Isola J. Stromal cell cathepsin D expression and long-term survival in breast cancer. Br. J. Cancer. 71:1995;155-159.
12. Hurlimann J., Gebhard S., Gomez F. Oestrogen receptor, progesterone receptor, PS2, ERD5, HSP27, and D in invasive ductal breast carcinomas. Histopathology. 23:1993;239-248.
13. Eng Tan P., Benz C.C., Dollbaum C.et al. Prognostic value of cathepsin D expression in breast cancer: immunohistochemical assessment and correlation with radiometric assay. Ann. Oncol. 5:1994;329-336.
14. Sehadri R., Horsfall D.J., Firgaira F.et al. The relative prognostic significance of total cathepsin D and HER-2/neu oncogene amplification in breast cancer. Int. J. Cancer. 56:1994;61-65.
15. Foekens J.A., van Putten W.L.J., Protengen H. Prognostic value of PS2 and cathepsin D in 710 human primary breast tumors: multivariate analysis. J. Clin. Oncol. 11:1993;899-908.
16. Namer, M., Ramaioli, A., Fontana, X. et al. (1991) Prognostic value of total cathepsin D in breast tumors, Breast Cancer Res. Treat., 19, 85-93.
17. Ferno M., Baldetorp B., Borg A.et al. Cathepsin D, both a prognostic and a predictive factor for the effect of adjuvant tamoxifen in breast cancer. Eur. J. Cancer. 30A:1994;2042-2048.
18. Gion M., Mione R., Pappagallo G.L.et al. Biochemical parameters for prognostic evaluation in patients with breast cancer. Anticancer Res. 14:1994;693-698.
19. Janicke F., Schmitt M., Pache L.et al. Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer. Breast Cancer Res. Treat. 24:1993;195-208.
20. Granata G., Coradini D., Cappelletti V., Di Fronzo G. Prognostic relevance of cathepsin D versus oestrogen receptors in node-negative breast cancers. Eur. J. Cancer. 27:1991;970-972.
21. Kute T.E., Shao L.-M., Sugg N.K.et al. Cathepsin D as a prognostic indicator for node-negative breast cancer patients using both immunoassays and enzymatic assays. Cancer Res. 52:1992;1-6.
22. Spyratos F., Brouillet J.-P., Defrenne A. Cathepsin D: an independent prognostic factor for metastasis of breast cancer. Lancet. 327:1989;115-118.
23. Romain S., Muracciole X., Varette I.et al. La cathepsin-D: un facteur prognostique independant dans le cancer du sein. Bull. Cancer. 77:1990;439-447.